Clinical Research

Left atrial appendage occlusion (LAAO) with the Watchman FLX device from Boston Scientific is associated with positive outcomes and limited adverse events after one year, according to new findings published in Circulation: Cardiovascular Interventions.[1] Many prior Watchman FLX studies, including PINNACLE FLX, had focused on the device’s performance in a controlled setting. The study’s authors hoped to gain a better understanding of its real-world impact by reviewing registry data from more than 97,000 U.S

LAAO with Watchman FLX associated with positive 1-year outcomes, real-world data confirm

Researchers hoped to gain a better understanding of the device's real-world impact by reviewing registry data from more than 97,000 U.S. patients. Overall, the Watchman FLX was linked to positive data and limited adverse events one year after treatment. 

Study calls for MRI follow-up in concussion patients

Follow-up MRI in patients with mild traumatic brain injuries could help predict if they will experience lingering symptoms months later, even if their initial imaging was normal.

The J-Valve manufactured by JC Medical, a Genesis MedTech company, includes a self-expanding nitinol frame, bovine pericardial leaflets and three anchor rings designed to assist operators with alignment. Its delivery system was built with transfemoral access in mind, and JC Medical plans to offer the valve in five different sizes.

New TAVR valve for native aortic regurgitation linked to positive 30-day outcomes

The J Valve from JC Medical was linked to positive outcomes and “excellent” hemodynamic data after 30 days in an early feasibility study published in JACC: Cardiovascular Interventions. Researchers noted that the valve showed potential in patients with large aortic annuli, which represents an "unmet critical need" at this stage. 

Thumbnail

New research argues for MRI in all prostate cancer patients, even those considered low-risk

The study's findings indicate that obtaining a prostate MRI at the time of a patient's initial diagnosis may provide important insight into how cancer will progress over time.

Cardiovalve heart valve transfemoral TMVR TTVR

Cardiologists first in world to use new heart valve for TMVR, TTVR on same patient

Identical Cardiovalve systems were used to perform the procedures 18 months apart on a high-risk heart patient. 

Bayer finerenone Kerendia heart failure MOONRAKER

Bayer’s finerenone benefits heart failure patients

Finerenone, sold under the brand name Kerendia, is already approved by the FDA for reducing heart and kidney risks in patients with chronic kidney disease (CKD) and type 2 diabetes. Bayer plans on presenting the new data in full at ESC Congress 2024 in London. 

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

MRI scans show effect of MIND diet on brain health

The MIND diet is a combination of the DASH (Dietary Approaches to Stop Hypertension) and Mediterranean diets.

Dr. Masoud Pezeshkian speaking at the endorsement ceremony for Iranian president this week, with Iran's Supreme Leader Ayatollah Ali Khamenei. Photo courtesy off the Government of the Islamic Republic of Iran

World spotlight shines on cardiac surgeon elected president of Iran

Cardiac researcher Masoud Pezeshkian, MBBS, became one of the world's most widely known cardiac surgeons in the world when he officially became Iran's president.